Pegfilgrastim Overview Categories 10 Drugs affecting the blood10.4 Anabolics & hematopoietics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pegfilgrastim Manufacturers of Pegfilgrastim Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pegfilgrastim's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 6 to 6 mg6 (6)As recommended.Sc6 mg administered subcutaneously once per chemotherapy cycle. Do not administer between 14 days before and 24 hours after administration of cytotoxic chemotherapy. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Pegfilgrastim is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Pegfilgrastim is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pegfilgrastim Back to top Manufacturers of Pegfilgrastim in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Pegfilgrastim Overview Categories 10 Drugs affecting the blood10.4 Anabolics & hematopoietics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pegfilgrastim Manufacturers of Pegfilgrastim Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pegfilgrastim's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 6 to 6 mg6 (6)As recommended.Sc6 mg administered subcutaneously once per chemotherapy cycle. Do not administer between 14 days before and 24 hours after administration of cytotoxic chemotherapy. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Pegfilgrastim is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Pegfilgrastim is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pegfilgrastim Back to top Manufacturers of Pegfilgrastim in Pakistan Back to top Previous Drug Generic - Next Drug Generic